APA (7th ed.) Citation

TE, W., KM, L., MQ, L., SR, H., A, D., S, K., . . . SV, R. (2013). A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma. Leukemia, 27(1), 220. https://doi.org/10.1038/leu.2012.236

Chicago Style (17th ed.) Citation

TE, Witzig, et al. "A Phase III Randomized Trial of Thalidomide Plus Zoledronic Acid Versus Zoledronic Acid Alone in Patients with Asymptomatic Multiple Myeloma." Leukemia 27, no. 1 (2013): 220. https://doi.org/10.1038/leu.2012.236.

MLA (9th ed.) Citation

TE, Witzig, et al. "A Phase III Randomized Trial of Thalidomide Plus Zoledronic Acid Versus Zoledronic Acid Alone in Patients with Asymptomatic Multiple Myeloma." Leukemia, vol. 27, no. 1, 2013, p. 220, https://doi.org/10.1038/leu.2012.236.